Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

EXCEL Trial, TCT 2016, drug-eluting stents, CABG, surgery left main heart disease, LMCAD

Gregg W. Stone, M.D., presenting the EXCEL data at TCT 2016 during a standing room only late-breaking trial session.

Feature | Stents | January 12, 2017 | Dave Fornell
The biggest news from the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting this past fall was the results...
Medinol, BIONICS study, 12-month results, TCT 2016, drug-eluting stent, EluNIR
News | Stents Drug Eluting | January 10, 2017
January 10, 2017 — Medinol announced in December positive twelve-month clinical results from the BIONICS study. The...
stroke, FDA seeks stroke registries, brain infarct
News | Stroke | January 02, 2017
January 2, 2017 — The U.S. Food and Drug Administration (FDA) hopes to build clinical evidence through new registries...
Absorb, bioresorbable stent, BVS, top cardiology story of 2016

The FDA clearance of the first fully bioresorbable stent, the Abbott Absorb BVS, was by far the top story of 2016. Readers clearly had a massive interest in this technology based on their page views of this article, related bioresorbable stent content and a video interviews with key ABSORB study investigators.

Feature | December 21, 2016 | Dave Fornell
The Diagnostic and Interventional Cardiology (DAIC) website had a record year in 2016, breaking 1 million page views...
Biotronik, Pulsar-18 bare metal self-expanding stent, BMS SE, BIOFLEX PEACE trial, 12-month results, VEITHsymposium 2016
News | Stents Peripheral | December 13, 2016
December 13, 2016 — Biotronik announced the presentation of data confirming the efficacy of the Pulsar-18 bare metal...
LimFlow System, critical limb ischemia, CLI, CE Mark
News | Stents Peripheral | December 08, 2016
December 8, 2016 — LimFlow SA announced in November that it received the CE Mark for its fully percutaneous LimFlow...
InspireMD, CGuard embolic protection system, EPS, clinical data, internal carotid artery stenosis, ICA
News | Stents Carotid | November 18, 2016
November 18, 2016 — InspireMD Inc. announced in mid-October the online publication of positive clinical data in a new...
fibrinolysis, FL, STEMI patients, ACCF/AHA guidelines, Minneapolis Heart Institute, AHA Scientific Sessions 2016
News | Cath Lab | November 10, 2016
November 10, 2016 — Current ACCF/AHA guidelines recommend fibrinolysis (FL) as the preferred reperfusion strategy for...
 PLATINUM DIVERSITY, stents in minorities and women
News | Cath Lab | November 09, 2016
November 9, 2016 — A dedicated stent study conducted exclusively in women and minority patients evaluated clinical...
Biotronik's Osiro stent, prison IV trial

Biotronik's Osiro ultra-thin strut, sirolimus-eluting stent.

News | Stents | November 09, 2016
November 9, 2016 – Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin...
Videos | Stents Bioresorbable | November 09, 2016
Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's...
Videos | Cath Lab | November 08, 2016
David Kandzari, M.D., director of interventional cardiology and chief scientific officer, Piedmont Heart Institute,...
OCT stent strut coverage

OCT imaging showing neointimal tissue coverage of metallic stent struts.

News | Stents | November 07, 2016
November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OCT...
biosensors Biofreedom stent
News | Stents | November 07, 2016
November 7, 2016 – The two-year results from LEADERS FREE, the first randomized clinical trial dedicated to high...
Fortitude bioresorbable stent

The Fortitude sirolimus-eluting bioresorbable stent.

 

News | Stents Bioresorbable | November 07, 2016
November 7, 2016 — The 28th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, Oct. 29-Nov. 3...